Literature DB >> 27414766

Myeloperoxidase: a key regulator of neutrophil oxidant production.

A J Kettle1, C C Winterbourn1.   

Abstract

Myeloperoxidase plays a fundamental role in oxidant production by neutrophils. This heme enzyme uses hydrogen peroxide and chloride to catalyze the production of hypochlorous acid, which is the major strong oxidant generated by neutrophils in appreciable amounts. In addition to chlorination, myeloperoxidase displays several other activities. It readily oxidizes thiocyanate to hypothiocyanite, converts a myriad of organic substrates to reactive free radicals, and hydroxylates aromatic compounds. Depending on the concentration of its competing substrates and the conditions of the local environment, myeloperoxidase could substantially affect oxidant production by neutrophils. Superoxide is undoubtedly a physiological substrate for myeloperoxidase. Its interactions with the enzyme are key factors in determining how neutrophils use superoxide to kill pathogens and promote inflammatory tissue damage. Superoxide modulates the chlorination and peroxidation activities of myeloperoxidase. It also reacts with the enzyme to form oxymyeloperoxidase which is catalytically active and hydroxylates phenolic substrates. Myeloperoxidase reacts rapidly with nitric oxide and peroxynitrite so that at sites of inflammation there is a strong possibility that these reactions will impact on oxidative damage caused by neutrophils. Under certain conditions, many substrates of myeloperoxidase act as inhibitors and regulate oxidant production by the enzyme. Given the numerous reactions of myeloperoxidase, all its activities should be considered when assessing the injurious oxidants produced by neutrophils.

Entities:  

Year:  1997        PMID: 27414766     DOI: 10.1080/13510002.1997.11747085

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  61 in total

1.  Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

Authors:  Goksel Sener; Figen Onuk Goren; Nefise B Ulusoy; Yasemin Ersoy; Serap Arbak; Gül Ayanoglu Dülger
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  Chlorinated Flavonoids Modulate the Inflammatory Process in Human Blood.

Authors:  Carina Proença; Daniela Ribeiro; Tânia Soares; Sara M Tomé; Artur M S Silva; José L F C Lima; Eduarda Fernandes; Marisa Freitas
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

3.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  The presence of modified nucleosides in extracellular fluids leads to the specific incorporation of 5-chlorocytidine into RNA and modulates the transcription and translation.

Authors:  Caroline Noyon; Thierry Roumeguère; Cédric Delporte; Damien Dufour; Melissa Cortese; Jean-Marc Desmet; Christophe Lelubre; Alexandre Rousseau; Philippe Poelvoorde; Jean Nève; Luc Vanhamme; Karim Zouaoui Boudjeltia; Pierre Van Antwerpen
Journal:  Mol Cell Biochem       Date:  2017-01-10       Impact factor: 3.396

5.  Immune evasion by a staphylococcal inhibitor of myeloperoxidase.

Authors:  Nienke W M de Jong; Kasra X Ramyar; Fermin E Guerra; Reindert Nijland; Cindy Fevre; Jovanka M Voyich; Alex J McCarthy; Brandon L Garcia; Kok P M van Kessel; Jos A G van Strijp; Brian V Geisbrecht; Pieter-Jan A Haas
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

6.  Degradation of extracellular matrix and its components by hypobromous acid.

Authors:  Martin D Rees; Tane N McNiven; Michael J Davies
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

7.  Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.

Authors:  Göksel Sener; A Ozer Sehirli; Hale Z Toklu; Meral Yuksel; Feriha Ercan; Nursal Gedik
Journal:  Pediatr Surg Int       Date:  2007-01-10       Impact factor: 1.827

8.  Protective effect of melatonin against ischemia/reperfusion-induced oxidative remote organ injury in the rat.

Authors:  Ayhan Kaçmaz; E Yilmaz User; A Ozer Sehirli; Metin Tilki; Sirri Ozkan; Göksel Sener
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

9.  The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages.

Authors:  Amanda E Lane; Joanne T M Tan; Clare L Hawkins; Alison K Heather; Michael J Davies
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

10.  Serum myeloperoxidase level predicts reperfusion in patients with myocardial infarction receiving thrombolytic therapy.

Authors:  Bilgehan Karadag; Bulent Vatan; Yalcin Hacioglu; Dursun Duman; Murat Baskurt; Ibrahim Keles; Zeki Ongen; Vural Ali Vural
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.